Processa Pharmaceuticals, Inc.

PCSA · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 12 employees
259
SEC Filings
$1.87
Close 2026-11-10
12
Employees

Business Summary

Processa Pharmaceuticals is a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies by modifying existing FDA-approved cancer drugs to improve safety-efficacy profiles. Key pipeline assets include PCS6422 (NGC-Cap, a capecitabine combination in Phase 2 for breast cancer) and PCS11T (NGC-Iri, an irinotecan analog in preclinical development). The company also has two non-oncology assets (PCS12852 for gastroparesis and PCS499 for glomerular disease) being evaluated for out-licensing, and has adopted a digital asset treasury strategy.

Latest Stock Quote

PCSA 2026-11-10 $1.87 O:$1.9 H:$1.95 L:$1.85 Vol:0.0M VWAP:$1.8939
origin leaf: null

Next Earnings

expected 2027-01-28

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-182025-12-310001493152-26-011204EDGAR64K words
2025-03-202024-12-310001641172-25-000070EDGAR74K words
2024-03-292023-12-310001493152-24-011976EDGAR61K words
2023-03-302022-12-310001493152-23-009730EDGAR60K words
2022-03-302021-12-310001493152-22-008156EDGAR63K words
2021-03-252020-12-310001493152-21-006807EDGAR61K words
2020-03-062019-12-310001493152-20-003534EDGAR71K words
2019-03-282018-12-310001493152-19-004137EDGAR57K words
2018-04-162017-12-310001493152-18-005248EDGAR56K words
2017-09-252016-12-310001393905-17-000290EDGAR29K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-132026-09-300001493152-26-051827EDGAR68K words
2026-08-142026-06-300001493152-26-038334EDGAR17K words
2025-11-062025-09-300001493152-25-021069EDGAR18K words
2025-08-072025-06-300001493152-25-011685EDGAR15K words
2025-05-082025-03-310001641172-25-009252EDGAR13K words
2024-10-302024-09-300001493152-24-043058EDGAR17K words
2024-08-132024-06-300001493152-24-031622EDGAR16K words
2024-05-102024-03-310001493152-24-018648EDGAR15K words
2023-11-132023-09-300001493152-23-040472EDGAR19K words
2023-08-102023-06-300001493152-23-027551EDGAR17K words
2023-05-152023-03-310001493152-23-017001EDGAR14K words
2022-11-082022-09-300001493152-22-030942EDGAR21K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-050001140361-26-042044EDGAR2K words
2026-11-040001140361-26-041901EDGAR1K words
2026-10-290001140361-26-041116EDGAR1K words
2026-08-040001493152-26-036032EDGAR1K words
2026-07-290001493152-26-035099EDGAR2K words
2026-02-190001493152-26-007469EDGAR1K words
2026-01-070001493152-26-000733EDGAR1K words
2025-12-150001493152-25-027680EDGAR1K words
2025-09-120001493152-25-013108EDGAR1K words
2025-09-100001493152-25-012966EDGAR1K words

259 total filings indexed. 227 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

oncology-(breast,-colorectal,-gastrointestinal,-pancreatic,-lung,-ovarian,-cervical-cancers) gastroparesis primary-glomerular-disease-(fsgs,-iga-nephropathy) digital-asset-treasury fda-project-optimus-initiative fda-regulatory-science-approach fda-draft-guidance-optimus-2025

Company Identity

CIK0001533743
TickerPCSA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersVero Beach, FL
Websitehttps://www.processapharmaceuticals.com
Listed2013-10-07

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 255a408689648a33150cfe5750544f869e3f04ee27471ac6825e3bffde9eed70
parent: 47356f095a3d5d38f222e759581e26a287e0a40dfe41362c4d088882239d4647
content hash: 997c9cdd6c613782823810014da5013c89c91fa2b6dd58f53cd03eeb0b765c63
signed: 2026-11-16T19:04:06.692Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up PCSA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on PCSA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/PCSA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.